ZIM
AMED

Zacks Investment Management’s Amedisys AMED Stock Holding History

Zacks Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-72,165
Closed -$17.7M – 596
2021
Q2 		$17.7M Buy
72,165
+4,085
+6% +$1.07M 0.29% 95
2021
Q1 		$18M Sell
68,080
-2,994
-4% -$844K 0.32% 91
2020
Q4 		$20.8M Sell
71,074
-1,113
-2% -$285K 0.38% 79
2020
Q3 		$17.1M Sell
72,187
-1,571
-2% -$357K 0.35% 80
2020
Q2 		$14.6M Sell
73,758
-14,136
-16% -$2.64M 0.32% 82
2020
Q1 		$16.1M Sell
87,894
-6,559
-7% -$1.17M 0.4% 70
2019
Q4 		$15.8M Buy
94,453
+837
+0.9% +$124K 0.3% 82
2019
Q3 		$12.3M Sell
93,616
-5,384
-5% -$701K 0.25% 93
2019
Q2 		$12M Buy
99,000
+4,370
+5% +$519K 0.25% 93
2019
Q1 		$11.7M Buy
94,630
+10,140
+12% +$1.27M 0.25% 92
2018
Q4 		$9.89M Buy
84,490
+6,404
+8% +$755K 0.24% 97
2018
Q3 		$9.76M Buy
78,086
+3,443
+5% +$380K 0.2% 107
2018
Q2 		$6.38M Sell
74,643
-142
-0.2% -$10.4K 0.14% 129
2018
Q1 		$4.51M Buy
+74,785
New +$4.26M 0.1% 160

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Zacks Investment Management's AMED Position: Q3 2021 in Review

Zacks Investment Management sold out of Amedisys (AMED) in Q3 2021, closing a stake of 72,165 shares — an estimated $17.7M sold.

Zacks Investment Management first reported a position in AMED in Q1 2018 and held it in 14 quarters. The position peaked at $20.8M in Q4 2020. 352 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Zacks Investment Management reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Zacks Investment Management sold 72,165 Amedisys shares in Q3 2021, an estimated $17.7M.
  • Zacks Investment Management first reported a position in Amedisys in Q1 2018 and held it in 14 quarters.
  • Zacks Investment Management's Amedisys position peaked at $20.8M in Q4 2020.
  • 352 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Zacks Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.